Pregnancy Outcomes for Frozen-Thawed Day 5 Blastocyst Transferred After Different Duration of Progesterone Supplementation in Hormone Replacement Therapy Cycle

Yanhong Mao,Zhidan Hong,Chun Zhou,Bo Zhang,Ming Zhang,Ling Ma
2021-01-01
Journal of reproductive medicine
Abstract:OBJECTIVE: To study the differences in clinical outcomes between frozen-thawed blastocyst transfer (FET) on the 6th day and 7th day of progesterone supplementation in hormone replacement treatment (HRT) cycle. STUDY DESIGN: A retrospective cohort study was designed. 446 patients who received HRT protocol to prepare the endometrium for FET of day 5 blastocysts were enrolled. In group A (n=266), day 5 blastocysts were transferred on the 7th day of progesterone supplementation, and in group B (n=180), day 5 blastocysts were transferred on the 6th day of progesterone supplementation. RESULTS: There was no significant difference in implantation rate (48.00% vs. 46.71%, p> 0.05) and clinical pregnancy rate (62.78% and 58.33%, p> 0.05) between the 2 groups. However, significant difference was observed in miscarriage rate, specifically, 9.60% in group A and 25.71% in group B (p< 0.001). The live birth rate (LBR) in group A was significantly higher than in group B (56.77% vs. 43.33%, p=0.005). By multivariable logistic regression adjusted for confounding factors, it was found that the LBR significantly correlated with the duration of progesterone supplementation before FET (aOR=1.694, 95% CI 1.128-2.544, p=0.011). CONCLUSION: The miscarriage rate decreased and live birth rate increased for FET of day 5 blastocysts undertaken on the 7th day of progesterone supplementation as compared with that on the 6th day.
What problem does this paper attempt to address?